secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inogen Inc (INGN)
CIK:        0001294133
Form:       8-K
Filed at:   2026-09-30T20:10:25+00:00
Accession:  0001294133-26-000037
Event type: m_and_a
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 7.01, 8.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Inogen to divest U.S. oxygen rental business to Rotech for up to $25M; buyback raised to $45M
--------------------------------------------------------------------------------

- Asset Purchase Agreement signed Sept 29, 2026; Rotech buys Inogen's U.S. rental assets including on-rent/on-hand inventory and patient records for up to ~$24.8M in six installments.
- Deal expected to close in Q4 2026 subject to customary conditions; Rental Business had $24.3M H1 2026 revenue, down 9.8% YoY, and will be reported as discontinued operations from Q3 2026.
- Separate long-term supply agreement has Rotech distributing Inogen oxygen concentrators through its national network to accelerate patient demand.
- Board approved a $15M increase to the share repurchase authorization, to $45M total, effective only on deal close; expiration extended from Dec 31, 2027 to June 30, 2028.
- CEO Kevin Smith said the deals strengthen Inogen's business and financial profile; company expects higher revenue growth rate and adjusted operating income.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1294133/000129413326000037/0001294133-26-000037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1294133/000129413326000037/ingn-20260928.htm
  HTML page:      https://secwatch.observer/filing/0001294133-26-000037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer